-+ 0.00%
-+ 0.00%
-+ 0.00%

Conexeu Sciences Launches Human Collagen Program for Regenerative Aesthetics

PUBT·11/10/2026 13:35:32
Conexeu Sciences Launches Human Collagen Program for Regenerative Aesthetics
  • Conexeu Sciences launched a human collagen initiative for regenerative aesthetics, targeting tissue restoration associated with aging and GLP-1-related weight loss.
  • Previously reported results from the 12-month P.R.O.O.F. preclinical study met objectives for CXU; full results are being prepared for peer-reviewed publication.
  • The first internally produced human collagen pilot batch met predefined specifications, supporting efforts to control ingredient quality.
  • Lead device candidate Ten Minute Tissue remains on track for a planned FDA 510(k) submission in the first quarter of 2027, pending testing.
  • Wound care is the expected first commercial indication, subject to FDA clearance; human collagen products would require separate regulatory review.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Conexeu Sciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611100830PRIMZONECNPR____9873977) on November 10, 2026, and is solely responsible for the information contained therein.